To the Editor: We thank Page and colleagues for their important article considering the sociodemographic correlates of antidepressant utilisation in Australia.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Page AN, Swannell S, Martin G, et al. Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust 2009; 190: 479-483. <MJA full text>
- 2. Hetrick S, Merry S, McKenzie J, et al. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007; (3): CD004851.
- 3. UK National Collaborating Centre for Mental Health on behalf of the National Institute for Health and Clinical Excellence. Depression in children and young people. Identification and management in primary, community and secondary care. Leicester: British Psychological Society, 2005. http://www.nice.org.uk/guidance/CG28 (accessed Sep 2009).
- 4. Royal Australian College of General Practitioners. Clinical guidance on the use of antidepressant medications in children and adolescents. Melbourne: RACGP, 2007. http://www.racgp.org.au/guidelines/ssris (accessed Sep 2009).
- 5. Hetrick S, Simmons M, Merry S. SSRIs and depression in children and adolescents: the imperative for shared decision-making. Australas Psychiatry 2008; 16: 354-358.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Acknowledgement: Magenta Simmons is funded by an Ian Scott Scholarship from Australian Rotary Health.